Literature DB >> 20680035

Pitfalls in the use of HbA₁(c) as a diagnostic test: the ethnic conundrum.

Samuel Dagogo-Jack1.   

Abstract

The purpose of a diagnostic test is to identify individuals who have a disorder and reassure those who do not. An HbA₁(c)-based diagnosis of diabetes mellitus or prediabetes fails to meet that purpose. Diabetes mellitus is a disorder of glucose, not HbA₁(c), metabolism. Microvascular complications in diabetes mellitus are driven by chronic hyperglycemia. The correlation of these complications with HbA₁(c) levels is convenient; however, unlike the direct information provided by glucose, HbA₁(c) values reflect glycemic and nonglycemic factors. The latter include modulators of glucose transport across the erythrocyte membrane, intracellular protein glycation and deglycation, erythrocyte turnover, systemic illness and hematological and medical disorders, among others. Genetic rather than glycemic factors explain most of the variance in HbA₁(c) levels. Finally, HbA₁(c) values are misleading as a measure of average blood glucose among persons of African, Asian, Hispanic and other non-European ancestry. Given the numerous pitfalls, the use of HbA₁(c) levels for diagnosing diabetes mellitus or prediabetes is ill-advised.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680035     DOI: 10.1038/nrendo.2010.126

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  29 in total

1.  Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia.

Authors:  B J Gould; S J Davie; J S Yudkin
Journal:  Clin Chim Acta       Date:  1997-04-04       Impact factor: 3.786

2.  HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins.

Authors:  H Snieder; P A Sawtell; L Ross; J Walker; T D Spector; R D Leslie
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

3.  Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies.

Authors:  David C Ziemer; Paul Kolm; William S Weintraub; Viola Vaccarino; Mary K Rhee; Jennifer G Twombly; K M Venkat Narayan; David D Koch; Lawrence S Phillips
Journal:  Ann Intern Med       Date:  2010-06-15       Impact factor: 25.391

4.  High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.

Authors:  James M Hempe; Ricardo Gomez; Robert J McCarter; Stuart A Chalew
Journal:  J Diabetes Complications       Date:  2002 Sep-Oct       Impact factor: 2.852

5.  Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006.

Authors:  Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Edward W Gregg; Earl S Ford; Linda S Geiss; Kathleen E Bainbridge; Judith E Fradkin
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 19.112

6.  Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

Authors:  William H Herman; Kathleen M Dungan; Bruce H R Wolffenbuttel; John B Buse; Jessie L Fahrbach; Honghua Jiang; Sherry Martin
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.

Authors:  William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

9.  Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors.

Authors:  Darrell M Wilson
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

10.  A1C and diabetes diagnosis: The Rancho Bernardo Study.

Authors:  Caroline K Kramer; Maria Rosario G Araneta; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more
  47 in total

1.  Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Authors:  Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher
Journal:  Tuberculosis (Edinb)       Date:  2018-08-18       Impact factor: 3.131

2.  A conundrum addressed: the prognostic value of HbA1c.

Authors:  Elizabeth Selvin; Frederick L Brancati
Journal:  Nat Rev Endocrinol       Date:  2011-01       Impact factor: 43.330

Review 3.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

4.  Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors.

Authors:  Emily R Perito; Robert H Lustig; Philip Rosenthal
Journal:  J Pediatr       Date:  2016-12-29       Impact factor: 4.406

5.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

Review 6.  How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.

Authors:  S Fuji; A Rovó; K Ohashi; M Griffith; H Einsele; M Kapp; M Mohty; N S Majhail; B G Engelhardt; A Tichelli; B N Savani
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

7.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Authors:  Kerry J Welsh; M Sue Kirkman; David B Sacks
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

8.  Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.

Authors:  Rosaley Prakaschandra; Datshanna Prakesh Naidoo
Journal:  Ethn Dis       Date:  2018-02-01       Impact factor: 1.847

9.  Racial differences in glycemic markers: a cross-sectional analysis of community-based data.

Authors:  Elizabeth Selvin; Michael W Steffes; Christie M Ballantyne; Ron C Hoogeveen; Josef Coresh; Frederick L Brancati
Journal:  Ann Intern Med       Date:  2011-03-01       Impact factor: 25.391

10.  Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference.

Authors:  Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.